ESSIC 2023
New York, 6-8 July
PROGRAMME
The Scientific programme of the ESSIC 2023 Annual Meeting has been designed by the ESSIC Executive Board in collaboration with Prof. Robert Moldwin, ESSIC 2023 Meeting Chair and ESSIC Vice-President
6 JUL
Welcome and Introduction; The History and Future of ESSIC
01.00 pm
M. Cervigni, R. Moldwin
6 JUL
SESSION 1 - How do we define what we treat? Nomenclature, Taxonomy, Medical Coding
01.15 pm
Moderators: Philip Hanno, Kazumasa Torimoto
6 JUL
IC/BPS Guidelines Around the World…Will We Ever Agree?
01.15 pm
P. Hanno
6 JUL
Hunner Lesions: Should We Classify as a Rare Disease?
01.30 pm
C. Riedl
6 JUL
ICD-11 Primary Bladder Pain Syndrome: Time for a Name Change?
01.45 pm
J. Fariello Moldwin
6 JUL
ERN eUrogen Progress
02.00 pm
M. Cervigni
6 JUL
Q&A / Round Table
02.15 pm
P. Hanno, C. Riedl, M.Cervigni
6 JUL
Coffee Break
02.30 pm
Coffee Break
6 JUL
SESSION 2 - Widespread and Local Pathophysiology
02.45 pm
Moderators: Lori Birder, Dick Janssen
6 JUL
Free radicals: A role in IC/BPS Pathophysiology?
02.45 pm
L. Birder
6 JUL
Widespreadness of Pain in the IC/BPS Patient
03.00 pm
JJ Wyndaele
6 JUL
Growth factor-mediated peripheral mechanisms in IC/BPS and CP/CPPS
03.30 pm
N. Yoshimura
6 JUL
Hunner lesion interstitial cystitis and other chronic cystitis: Similarities and differences in genomic pathology
03.45 pm
Y. Akiyama
6 JUL
Cellular Events within the Hunner lesion
04.00 pm
J. Stern
6 JUL
Biomarker Update
04.15 pm
K. Torimoto
6 JUL
Q&A / Round Table
04.30 pm
L. Birder, N. Yoshimura, Y. Akiyama, J. Stern, K. Torimoto
6 JUL
Abstracts Session I: Oral /Podium Presentations
04.45 pm
Moderators: Michel Pontari, Claus Riedl
6 JUL
Closing Remarks
05.50 pm
M. Cervigni, R. Moldwin
7 JUL
Breakfast/ Exhibits
07.00 am
Breakfast/ Exhibits
7 JUL
SESSION 3 - Diagnostic Dilemmas
08.00 am
Moderators: Gustavo Luis Garrido, Mauro Cervigni
7 JUL
Welcome and Recap of previous day’s events
08.00 am
M. Cervigni, R. Moldwin
7 JUL
Is it IC/BPS, CP-CPPS, or Both?
08.15 am
M. Pontari
7 JUL
Co-morbid conditions in the IC/BPS patient: Detection and clinical significance
08.30 am
J. Quaghebeur
7 JUL
Office Cystoscopy versus bladder hydrodistention: pros and cons for patient management
08.45 am
R. Evans
7 JUL
The patient with the positive urine NGS report: What’s a clinician to do?
09.00 am
L. Ackerman
7 JUL
Three-step approach for proper diagnosis of bladder-centric IC using the artificial intelligence (AI) navigation for...
09.15 am
N. Yoshimura
7 JUL
Q&A / Round Table
09.30 pm
M. Pontari, J. Quaghebeur, R. Evans, A.L. Ackerman, N. Yoshimura
7 JUL
Coffee Break
09.45 am
Coffee Break
7 JUL
SESSION 4 - Diagnostic Dilemmas
10.00 am
Moderator: M. Cervigni, S. Malde
7 JUL
Dysuria: Evaluation and Clinical Significance
10.00 am
L. Ackerman
7 JUL
A Standardized method to Identify Pelvic Myofascial Pain
10.15 am
H. Lai
7 JUL
Endometriosis and BPS: Evil twins or Distant Cousins?
10.30 am
tbc
7 JUL
Imaging for the evaluation of Pelvic Pain: Indications and Options
10.45 am
G. Garrido
7 JUL
I thought that it was IC/BPS. It turned out to be something else. If only I had…
11.00 am
M. Cervigni
7 JUL
Q&A / Round Table
11.15 am
A.L. Ackerman, H. Lai, G.L. Garrido, M. Cervigni
7 JUL
Abstracts Session II: Oral / Podium Presentations
12.00 pm
Moderators: Dick Janssen, Michael Dimitrios Samarinas
7 JUL
Lunch / Exhibit
01.00 pm
Lunch / Exhibit
7 JUL
SESSION 5 - Treatment Strategies
02.00 pm
Moderators: Robert Moldwin, Kristene Whitmore
7 JUL
Phenotype-Based Care of the BPS/IC Patient
02.00 pm
H. Lai
7 JUL
Cognitive Behavioral Therapy: It’s Role for the Pelvic Pain Patient
02.15 PM
H. Poupore-King
7 JUL
Diet and IC/BPS: Evidence Based Approaches to Management
02.30 pm
R. Moldwin
7 JUL
The Role of Centrally Acting Medications for CPP
02.45 pm
S. Malde
7 JUL
Ophthalmologic Changes associated with pentosan-polysulfate: Cause and Effect? How much Concern?
03.00 pm
P. Mendes
7 JUL
Compounded Topical Therapies for Pelvic Pain
03.15 pm
K. Whitmore
7 JUL
Immunomodulation for the IC/BPS Patient: Current and Future Roles for the Treatment of IC/BPS
03.30 pm
M. Samarinas
7 JUL
Q&A/ Round table
03.45 pm
Q&A/ Round table
7 JUL
Adjournment / ESSIC BOD Meeting
04.00 pm
Adjournment / ESSIC BOD Meeting
8 JUL
Breakfast/ Exhibits
07.00 am
Breakfast/ Exhibits
8 JUL
Morning Welcome
07.50 am
R. Moldwin
8 JUL
SESSION 6 - Treatment Strategies
08.00 am
Moderators: Mauro Cervigni, Michael Dimitrios Samarinas
8 JUL
LECTURE: Targets for Future Therapies
08.00 am
L. Rodriguez
8 JUL
Current Clinical Trials for IC/BPS
08.30 am
D. Janssen
8 JUL
The Failure of Clinical Trials for Bladder Pain: What Course Corrections are Needed?
08.45 am
H. Lai
8 JUL
Current Treatment Strategies for High – Tone pelvic fllor muscle dysfunction
09.00 am
J.F Jhang
8 JUL
Q&A / Round Table
09.30 pm
Q&A / Round Table
8 JUL
Coffee Break
09.45 am
Coffee Break
8 JUL
SESSION 7 - Treatment Strategies
10.00 am
Moderator: Gustavo Garrido, Robert J. Evans
8 JUL
Nerve blocks/ablation/ligation for Pelvic Pain
10.00 am
H. Herati
8 JUL
Botulinum toxin A injections for the IC/BPS patient: Best Practice Strategies
10.15 am
P. Pinto
8 JUL
Update on Neuromodulation for CPP: From Periphery to Brain
10.30 am
J.J. Wyndaele
8 JUL
Surgical Approaches for the “End Stage Bladder”
10.45 am
N. Mishra
8 JUL
Q&A / Round Table
11.00 am
Q&A / Round Table
8 JUL
Coffee Break
11.15 am
Coffe Break
8 JUL
SESSION 8 - Patient Groups
11.30 am
Moderators: Mauro Cervigni, Claus Reidl
8 JUL
Global Concerns of Patient Support Organizations
11.30 am
L. Nasta
8 JUL
Engagement of Patients in Support Organizations: How can we do better?
11.15 am
L. Santurri
8 JUL
The Role of Patient Support Groups in Research
12.00 pm
J. Meijlink
8 JUL
Discussion
12.15 pm
Discussion
8 JUL
SESSION 9 - Diagnostic Dilemmas: Case Presentations
12.30 pm
Moderators: Mauro Cervigni, Robert Moldwin
8 JUL
Cases 1-4
12.30 pm
TBC
8 JUL
Concluding Remarks/ Adjournment
01.00 pm
Concluding Remarks/ Adjournment